Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Purchase of subscription rights and subscription for shares in the subsequent offering by primary insiders

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the subsequent offering (the “Subsequent Offering”) in Norwegian Energy Company ASA (the “Company”) as previously announced, latest on 12 August 2019. Marianne Lie, board member of the Company, has today through Fajoma Consulting AS, a

Nordic Nanovector ASA: Mandatory notification of trade - primary insider - correction

With reference to the previous notification of trade, the correct number of shares purchased today, 23 August 2019, by Malene Brondberg is not 1,722 shares, but 3,900 shares in Nordic Nanovector ASA (the "Company") at an average share price of NOK 25.38 per share. Following this transaction, Malene Brondberg owns 9,455 shares in the Company and holds 40,000 PSUs. This information is subject to duty of disclosure pursuant to Section 4-2 and Section 5-2 of the Norwegian Securities Trading Act.

Inhalation Sciences receives new order worth 1.8 MSEK

(Stockholm August 23 2019) Inhalation Sciences Sweden AB has received an order for a new PreciseInhale system from an existing customer with global lab facilities. The new order includes a range of exposure modules and PreciseInhale’s new customized nebulizer feature.CEO Lena Heffler: “I’m pleased to see this trend of existing customers returning to purchase a second instrument from ISAB. It speaks volumes about the quality of data, range of capabilities and important competitive edge PreciseInhale gives them”. ISAB’s PreciseInhale aerosol generator generates accurate in vivo and ex vivo

Crunchfish: Blippit on track for Q4 launch (Västra Hamnen)

Västra Hamnen Corporate Finance has released a research update on Crunchfish AB following its report for Q2 2019. The company shows progression in line with our economic scenario, which confirms our estimated fair value interval for the share.· App terminal getting ready for production · Gesture Control becoming more powerful and user friendly · We maintain our fair value per share estimates of SEK 32.60 – 51.80 In its report for Q2 2019, Crunchfish confirms that their business expansion is progressing according to plan. The report contains few surprises and the company’s

Salmones Camanchaca commits to become Carbon Neutral by 2025

•        Will implement a strategic plan that will prioritize reductions in the use of fossil fuels, electricity and refrigerants, which are the main sources of greenhouse gas (GHG) emissions of the Company, and will promote forest stewardship projects. •        Announcement was made in Oslo, Norway, in the context of its Capital Markets Day, the first to be carried out by a Chilean capital company in that country. Oslo, Norway, August 23, 2019.- Always seeking to reduce its environmental footprint and promote the sustainable development of aquaculture, Salmones Camanchaca reported

Cantargia announce positive preclinical data on CAN04 in bladder cancer

Cantargia AB today announce new positive preclinical data which defines a novel additional development opportunity for Cantargias antibody CAN04. The molecular target for CAN04, IL1RAP, has been detected on the cancer cells in approximately 80 % of patients with bladder cancer. Furthermore, a pronounced and statistically significant single agent activity was documented in an in vivo model of the disease. Given current treatment strategies of bladder cancer, there are several future opportunities for CAN04 in this disease.Cantargia’s antibody CAN04 binds IL1RAP with high affinity and

Interim report January – June 2019

APRIL – JUNE 2019 · Revenue amounted to MSEK 1,667 (1,616), an increase of 3%. Organically, a decline of 4.7%. · Operating profit was MSEK -137 (11), which included a write-down of intangible assets amounting to MSEK 124 (0) regarding operations in Finland and items affecting comparability of MSEK -25 (-25). · Adjusted EBITA was MSEK 47 (69) and the corres-ponding margin was 2.8% (4.3). · Net loss for the period was MSEK -142 (-11) · Earnings per share before and after dilution was SEK -4.35 (-0.65). · The period’s cash flow was MSEK 1 (-32). · Taxi 4x27 in Denmark

Cyxone strengthens team ahead of continued development of T20K and Rabeximod

Cyxone (publ.), a Swedish biotech in autoimmune diseases, today announced that the company is expanding its team with Malin Berthold as project manager for the next step in the development of Cyxone's clinical drug portfolio. Malin will primarily lead and coordinate the preclinical and clinical development programs in the company. She will be the company's primary contact with external key partners such as CROs, toxicology laboratories, pharmaceutical manufacturers, formulation experts, analysis laboratories and communication experts. Further responsibility is to regularly report the

Interim report January – June 2019

Profitability and acquisitions ahead of planApril – June January – June 20192019 ·  Net sales increased by 21.9 percent to SEK 2,624 (2,153) ·  Net million. Organic growth was 2.0 (8.5) percent.sales ·  Adjusted EBITA increased to SEK 215 (180) million, whichincreased by corresponds to an adjusted EBITA margin of 8.2 (8.4) percent.19.8 percent ·  Operating cash flow for the period was SEK 282 (231)to SEK 1,406 million.(1,174) ·  Eight acquisitions were made during the first half of themillion. year, which, on an annual basis

Enersize publishes the interim report for the first six months 2019

This is a translation of previously released news. Enersize Oyj ("Enersize" or the "Company") hereby submits a half-year report for the period January – June 2019. · Enersize develops and sells the cloud services LEAQS and Q+ for the improvement of energy efficiency of industrial compressed air systems for the global manufacturing industry. · Enersize has implemented radical changes in the company and has now begun an expansion with a new business model that has been confirmed by several new orders, most recently with one of Hankook's factories in China. · Enersize's turnover in H1

Exercise period for BrainCool’s warrants, TO3 2019-2022, 26 August – 9 September 2019

As part of our agreement with L1 Capital, BrainCool has distributed free warrants to the company's shareholders to reduce dilution. During the period of August 26 to September 9, 2019, holders of TO3 Warrants can exercise the Warrants and subscribe for new shares. One (1) TO3 can be exchanged for one (1) share during the period, at a price of SEK 7.00. In total BrainCool would receive approximately SEK 8,4 million if all Warrants of series TO3 were to be exercised. Holders of warrants who have their Warrants registered in custody at a bank or fund commissioner shall contact their

SRV Group Plc’s financial information in 2020

SRV GROUP PLC     STOCK EXCHANGE RELEASE     23 AUGUST 2019     12.30 EETSRV Group Plc’s financial information in 2020SRV Group Plc will publish the following financial information in 2020: · Financial Statement Release 2019 will be published on Thursday, 6 February 2020 at 8.30 am. · Annual Report 2019 (including the Financial Statements and the Report of the Board of Directors) will be published on Monday, 2 March 2020. · Interim Report for January-March 2020 will be published on Wednesday, 29 April 2020 at 8.30 am. · Half-year Report for January-June 2020 will be

Heimstaden AB considers issuance of hybrid bonds

Heimstaden AB (publ) (the “Company” or “Heimstaden”) has mandated Nordea and Swedbank as joint bookrunners to arrange investor meetings to investigate the possibility to issue hybrid bonds under the Company’s existing hybrid bond loan (ISIN SE0012455111). The hybrid bond loan has an outstanding amount of SEK 2,000,000,000, a framework amount of SEK 5,000,000,000 and a perpetual maturity with a Company’s first call date in approximately 5 years. Proceeds from the contemplated issue are to be used for general corporate purposes [including acquisitions within both Heimstaden and Heimstaden

The Museum of Fossil Fuels opens in Sweden – "A fossil-free life is soon a reality"

Sweden often tops global sustainability rankings. Now, the world's first fossil fuel museum is opening in the country. "The shift will go much faster than we think, especially in the area of transportation, and fossil-fuels will be a thing of the past," says Susanna Hurtig, Nordic Head of InCharge at Vattenfall, the power company that is initiator of the museum.In 2019, the sound of combustion engines, the scent of petrol and filling your fuel tank at your local petrol station are still normal everyday occurrences for most people. But not for much longer. The demand for emissions-free

OxThera receives positive decision from EMA on Paediatric Investigational Plan (PIP) for treatment of primary hyperoxaluria with Oxalobacter formigenes

STOCKHOLM, SWEDEN – August 23, 2019. OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), today announced that, based on a positive opinion from the Paediatric Committee (PDCO), the EMA has agreed to the proposed PIP for Oxalobacter formigenes in the treatment of primary hyperoxaluria.“We are pleased to announce this important regulatory milestone. The approval of the Paediatric Investigational Plan provides us with a clear development path for Oxabact in the treatment of paediatric patients with primary

Become an integration expert!

Date: September 19, 2019 We're excited to announce our upcoming integration event, the iCore Bootcamp. Expand your iCore knowledge and update yourself on the latest technical features and performance in iCore Integration Suite and iCore Cloud Services. The event is scheduled to take place in Göteborg on the 17th of September and in Stockholm on September the 19th.  Make sure to note the date in your calendar right now!  Read more and sign up for the event - iCore Bootcamp. 

Epiroc to expand production facility in Örebro, Sweden

Stockholm, Sweden: Epiroc, a leading productivity provider for the mining and infrastructure industries, will expand one of its main production facilities, in Örebro, Sweden, to boost productivity and ensure long-term efficiency.Epiroc will expand and consolidate its production capacity utilized by the Surface and Exploration Drilling division, including constructing a major new building hosting assembly and offices. Production efficiency will be strengthened in the process. In total, it involves a facility expansion of about 10,000 square meters. Construction will begin this year and the

UPM-Kymmene Corporation: Managers’ Transactions (Wahlroos)

UPM-Kymmene Corporation      Managers’ Transactions         23 August 2019 at 10:16 EET UPM-Kymmene Corporation: Managers’ Transactions (Wahlroos) UPM-Kymmene Corporation has on 22 August 2019 received the following notification which relates to the transfer of the Manager’s below mentioned financial instruments to his fully-owned company (Tetrao SPF SA): Person subject to the notification requirementName: Tetrao SPF SAPosition: Closely associated person(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Björn WahlroosPosition: Chairman

UPM-Kymmene Corporation: Managers’ Transactions (Wahlroos)

UPM-Kymmene Corporation      Managers’ Transactions         23 August 2019 at 10:15 EET UPM-Kymmene Corporation: Managers’ Transactions (Wahlroos) UPM-Kymmene Corporation has on 22 August 2019 received the following notification which relates to the transfer of the Manager’s below mentioned financial instruments to his fully-owned company (Tetrao SPF SA): Person subject to the notification requirementName: Björn WahlroosPosition: Chairman of the BoardIssuer: UPM-Kymmene CorporationLEI: 213800EC6PW5VU4J9U64 Notification type: INITIAL NOTIFICATION_________________________

NENT Group calls ‘First Responders’ to first original medical drama series

· Ten-part series to premiere exclusively on Viaplay in 2020 · ‘First Responders’ produced by SF Studios · NENT Group to premiere at least 20 original productions every year The Swedish medical drama series ‘First Responders’ will be the next original production from Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company. Filmed in the scenic Swedish mountain village of Åre, the 10-part series will premiere exclusively on NENT Group’s Viaplay streaming service across the Nordic region in 2020. ‘First Responders’ (Swedish title: ‘Åreakuten’)

BE Group changes Chairman of the Board in conjunction with Peter Andersson taking office as CEO on October 1, 2019

The Board of BE Group will, within short, convene an Extraordinary General Meeting to be held on September 18 in order to change the Chairman of the Board. The change, aligned with the Nomination Committee, will mean that Jörgen Zahlin replaces current Chairman, Petter Stillström, who will assume the role as regular Board member. Jörgen Zahlin, born 1964, is CEO of OEM International and has been a member of the BE Group Board of Directors since 2013.The Board of Directors has also decided that Peter Andersson will take office as new CEO of BE Group on October 1, 2019. I have, in my

There are no items matching the current filter
There are no more items matching the current filter
Back to top